Related Experiment Video
Updated: Aug 1, 2025

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Viral pericarditis following ocrelizumab in a multiple sclerosis patient
Giuseppina Miele1, Gianmarco Abbadessa2, Elisabetta Maida2
1Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Vanvitelli, Via Pansini 5, 80131, Naples, Italy. giuseppinamiele20@gmail.com.
Abstract:
Ocrelizumab is a humanized monoclonal anti-CD20 antibody, approved for the treatment of relapsing and primary-progressive multiple sclerosis. We reported a case of pericarditis in an RRMS patient treated with ocrelizumab, who presented with chest pain, high body temperature and laboratory findings of systemic inflammation, with a favorable clinical outcome.
More Related Videos
Related Concept Videos
Pericarditis I: Introduction
Pericarditis III: Medical Management
Pericarditis IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Myocarditis I: Introduction

